FIELD: medicine.
SUBSTANCE: said pathology is simulated by a single subcutaneous introduction of native human plasma mixed with Freund adjuvant in equal proportions into Syrian hamsters. Plasma is injected both in symmetrical axillary and inguinal regions, and intraperitoneally 0.1 ml in each point. An amyloidprotector is presented by galavit 0.28 mg/kg introduced every second day subcutaneously for 60 days into the animals.
EFFECT: method is easily reproducible, provides effective correction of a nephropathic form of generalised amyloidosis promoting amyloidoclasia.
3 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS | 2011 |
|
RU2473134C2 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATIC FORM IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2381797C1 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC CONDITION IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2386415C1 |
| METHOD FOR SIMULATION OF EXPERIMENTAL AMYLOIDOSIS IN ANIMALS | 2010 |
|
RU2446482C1 |
| METHOD OF PREVENTING SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATIC FORM IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410764C1 |
| METHOD OF MODELLING EXPERIMENTAL AMYLOIDOSIS IN RATS | 2009 |
|
RU2410761C1 |
| METHOD FOR SIMULATING GENERALISED AMYLOIDOSIS IN ANIMALS | 2013 |
|
RU2536556C2 |
| METHOD OF TREATMENT AN EXPERIMENTAL AMYLOID CARDIOPATHY IN RATS | 2017 |
|
RU2657844C1 |
| METHOD FOR SIMULATING EXPERIMENTAL AMYLOID CARDIOPATHY IN RATS | 2013 |
|
RU2556571C1 |
| METHOD FOR PROPHYLAXIS AND TREATMENT OF SYSTEMIC AMYLOIDOSIS AND NEPHROPATHIC FORM THEREOF IN EXPERIMENTAL ANIMALS | 2004 |
|
RU2270672C1 |
